Clinical Trial Update: PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a combination of PEG-rhGH and semaglutide for obesity in non-diabetic adults; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• PEG-rhGH (pegylated recombinant human growth hormone)
• semaglutide (semaglutide)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Non-diabetic Obesity | Phase 4 | Status: NOT_YET_RECRUITING